Infectious Disease Clinical Trials

43 recruitingLast updated: June 18, 2026

There are 43 actively recruiting infectious disease clinical trials across 35 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4. Top locations include Melbourne, Victoria, Australia, Chicago, Illinois, United States, Paris, France. Updated daily from ClinicalTrials.gov.


Infectious Disease Trials at a Glance

43 actively recruiting trials for infectious disease are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Melbourne, Chicago, and Paris. Lead sponsors running infectious disease studies include Institut National de la Santé Et de la Recherche Médicale, France, Sinovac Life Sciences Co., Ltd., and Barcelona Institute for Global Health.

Browse infectious disease trials by phase

Treatments under study

About Infectious Disease Clinical Trials

Looking for clinical trials for Infectious Disease? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infectious Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infectious Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 43 trials

Recruiting

Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV

ImmunodeficienciesHIVInfectious Diseases
National Institute of Allergy and Infectious Diseases (NIAID)2,419 enrolled2 locationsNCT00001281
Recruiting

Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)

Urinary Tract InfectionsAntiobiotic StewardshipEmerging Infectious Disease
Centre Hospitalier Intercommunal Creteil330 enrolled3 locationsNCT07559318
Recruiting

An International Observational Study of Adults With Acute Infection

Infectious Disease
University of Minnesota1,500 enrolled48 locationsNCT07069400
Recruiting
Phase 2

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

Haematological MalignancyBlood CancerFungal Infection+1 more
The University of Queensland104 enrolled7 locationsNCT06510699
Recruiting
Not Applicable

Prescription Support System for Antimicrobial Use in Belgian Primary Care

Infectious Diseases
KU Leuven48 enrolled1 locationNCT07347015
Recruiting
Not Applicable

Fostering Prosocial Preventive Behaviours Through Awe

Infectious Diseases
The University of Hong Kong456 enrolled1 locationNCT07406529
Recruiting
Not Applicable

L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)

InfectionsChild, OnlyInfectious Disease
Barcelona Institute for Global Health2,200 enrolled2 locationsNCT06426147
Recruiting
Not Applicable

A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)

Febrile illnessChild, OnlyInfectious Disease
Barcelona Institute for Global Health5,212 enrolled2 locationsNCT06422338
Recruiting
Phase 1

Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers

PharmacologyInfectious Disease
Institut National de la Santé Et de la Recherche Médicale, France39 enrolled1 locationNCT06024421
Recruiting

Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions

Emerging Infectious DiseasesCommunicable DiseasesBiological Warfare Agents+2 more
Assistance Publique - Hôpitaux de Paris800 enrolled10 locationsNCT07411729
Recruiting
Phase 1

Clinical Trial of PCV24 in Infants Aged 2-23 Months

Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd.180 enrolled2 locationsNCT06800261
Recruiting
Phase 3

Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine

Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd.3,080 enrolled1 locationNCT06617715
Recruiting
Phase 2

PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months

Pneumococcal Infectious Disease
Shanghai Reinovax Biologics Co.,LTD480 enrolled7 locationsNCT07333352
Recruiting
Not Applicable

Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients

Incidence of Infectious Diseases
Pomeranian Medical University Szczecin100 enrolled1 locationNCT07308457
Recruiting
Phase 2

Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years

Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd.420 enrolled3 locationsNCT07300644
Recruiting
Phase 4

Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children

Complicated urinary tract infectionInfectionPediatric Infectious Disease
Murdoch Childrens Research Institute452 enrolled6 locationsNCT04876131
Recruiting
Phase 1

A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers

Infectious DiseasesAntimicrobial Drug Resistance
Bugworks Research Inc.48 enrolled1 locationNCT07029932
Recruiting

CytOSorb TreatMent Of Critically Ill PatientS Registry

SepsisLiver Transplant; ComplicationsPancreatitis+15 more
CytoSorbents, Inc3,000 enrolled28 locationsNCT05146336
Recruiting

Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

Genetic diseasesAllergyImmunology+1 more
Institut National de la Santé Et de la Recherche Médicale, France500 enrolled9 locationsNCT06762002
Recruiting
Not Applicable

Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections

Ear InfectionPediatric Infectious DiseaseAcute Otitis Media
Intermountain Health Care, Inc.1,566 enrolled3 locationsNCT06034080